Manufacturer Restriction Matrix
Since 2020, a growing number of drug manufacturers have limited 340B pricing at contract pharmacies or attached data-submission conditions. This matrix tracks who restricts what, which entity types are affected and what each manufacturer requires.
- Filterable by manufacturer and entity type
- Updated monthly once live
- Every entry sourced and dated
Contract pharmacy access has narrowed steadily since 2020.
Restrictions vary by manufacturer, entity type and sometimes state. Some policies limit 340B pricing to a single designated contract pharmacy, others require claims data, and some exempt entity-owned pharmacies or certain states.
Tracking policies by hand is time-consuming and error-prone. This matrix keeps the details together so pharmacy and finance teams can review potential exposure.
What each column means
Manufacturer
The manufacturer whose policy is listed.
Restriction type
How 340B pricing is limited, such as a designated contract pharmacy or required claims-data submission.
Entity types
The covered entity categories a policy may apply to.
State exemptions
Whether a policy identifies exemptions for pharmacies in states with protection laws.
Effective date and source
The effective date and source link for each verified policy. Demonstration rows are not current policy records.
Search and filter the matrix.
Demonstration rows are shown below; they do not describe current manufacturer policies. Published entries require a source and last-reviewed date.
| Manufacturer | Restriction type | Entity types | State exemptions | Effective | Source / reviewed |
|---|---|---|---|---|---|
| Manufacturer A | 340B ESP-style data submission required | Hospitals | Some states | Sample | Not verifiedReview pending |
| Manufacturer B | Contract pharmacy limited to one per entity | All covered entities | None | Sample | Not verifiedReview pending |
| Manufacturer C | Claims-level data required for replenishment | Hospitals, FQHCs | Several states | Sample | Not verifiedReview pending |
| Manufacturer D | No restriction currently in effect | All covered entities | N/A | Sample | Not verifiedReview pending |
Demonstration entries only; manufacturer names and policy details are placeholders, not current restrictions. Verified entries will include a source link and last-reviewed date before publication. Information is not legal advice; confirm current terms with the manufacturer before acting.
Demonstration entries only; they are not current manufacturer policies. Verify source material and current terms before acting. Not legal advice.
Turn the matrix into a plan.
After verifying which restrictions apply, quantify their impact on savings and patients, decide which pharmacy to designate where choice is allowed, and confirm data requirements can be met accurately.
- Model restriction exposure drug by drug
- Designate pharmacies strategically where permitted
- Meet claims-data submission requirements accurately
- Account for state law protections at each site
Questions about contract pharmacy policies
What is a 340B contract pharmacy restriction?
It is a manufacturer policy that limits when it will honor the 340B price on drugs shipped to a covered entity’s contract pharmacies, for example by limiting designated pharmacies or requiring claims data.
Do manufacturer restrictions apply to entity-owned pharmacies?
Terms vary by manufacturer. Review the current policy notice and confirm its application with the manufacturer and your counsel.
Do state laws affect manufacturer restrictions?
Some states have enacted laws addressing manufacturer contract pharmacy restrictions, and policies may identify state exemptions. Legal effect varies; consult qualified counsel on legal questions.